Trial Profile
Efficacy of trastuzumab in elderly patients with locally advanced or metastatic HER2-positive breast cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Nov 2014
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Advanced breast cancer; HER2 positive breast cancer
- Focus Therapeutic Use
- 14 Nov 2014 New trial record
- 01 Dec 2010 Recruitment completed, according to 50th Annual Meeting of the American Society of Clinical Oncology.